Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

EACR 2012 /
Underlying metabolic pathways in cancer

7th - 10th Jul 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 18.07.12
Views: 3474
Rating:

Dr Arkaitz Carracedo – Ikerbasque, Bilbao, Spain

Dr Arkaitz Carracedo discusses his research into the metabolic activity of cancer cells and how the differences between the metabolic pathways of cancer cells and normal cells can be used to produce new therapeutic agents. Dr Carracedo explains how this research has identified a pathway important to the propagation of breast cancer, explains why this pathway could help to explain the links between breast cancer and obesity, and outlines the stages that are necessary before these findings can be translated into clinical benefits.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation